Policy & Medicine - Legal, Regulatory, and Compliance Issues

On July 1, 2022, the “Transparency in Coverage” regulation aimed at health plans finally took effect after several years. The…

Earlier this year, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) conducted a…

AbbVie’s Allergan unit has allegedly reached an agreement to pay more than $2 billion to resolve lawsuits filed by state and local…

Earlier this year, Centene reached a $13.7 million settlement with the state of New Mexico over allegations that the company…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

Throughout 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) has made…

In early June 2022, the United States Food and Drug Administration (FDA) sent an Untitled Letter to Althera Pharmaceuticals, LLC,…

Recently, the Alliance for Continuing Education in the Health Professions published an article in the almanac about addressing…

On July 20, 2022, Greene LLP announced that Biogen, Inc. reached an agreement to pay $900 million to resolve claims brought by a…

On July 14, 2022, the United States Department of Justice (DOJ) announced a $9,853,958 settlement with BioReference Health LLC…